: Mycoplasma pneumoniae IgM Antibody, Serum, Semi-Quantitative

: What Is Being Tested?

: Mycoplasma pneumoniae is a common bacterium that causes respiratory infections, especially "walking pneumonia," particularly in school-age children and young adults. When the body is exposed to this bacterium, the immune system produces antibodies, including IgM (the type that typically appears first during an infection) and IgG (which tends to appear later and persist). This test measures the level of IgM antibodies specific to M. pneumoniae in the blood.

: How the Test Is Performed

: A healthcare professional collects a blood sample, usually from a vein in the arm, into a tube that yields serum. The serum is then analyzed in the laboratory using an immunoassay method that detects and estimates the amount of M. pneumoniae IgM antibodies. The result is typically reported semi-quantitatively (for example, as an index or titer value compared with a cutoff), rather than as a simple positive or negative.

: What the Results Mean

: An elevated or positive IgM result suggests that the immune system has recently encountered M. pneumoniae, supporting a diagnosis of recent infection. A negative result makes recent infection less likely but does not completely rule it out, especially if the sample was taken very early or very late after exposure. Because IgM can sometimes persist for months or cross-react with other conditions, results are best interpreted by a clinician in the context of symptoms, physical examination, and other tests.

: Important Limitations

: Antibody testing cannot distinguish between a current active infection and a recent past infection with certainty. IgM levels may be low in some infected people, particularly older adults or those tested very early. Some individuals may have false-positive results due to other infections or immune conditions. For these reasons, Mycoplasma IgM testing is usually one part of a broader evaluation and is not used alone to make treatment decisions.